By Karen Roman Oculis Holding AG (Nasdaq: OCS) said Phase 2 of its neuroprotective candidate OCS-05 met key endpoints of ...

The trial is designed to assess the tolerability, efficacy, and safety of two different dosages of the therapy.

Recent research has uncovered a link between diet, blood sugar control, and brain health in aging adults. The study, ...

Recent studies have identified the significance of mitophagy, a quality control process that removes dysfunctional ...

The primary safety endpoint was carried out through the percentage of patients with shift from normal (at baseline) to ...

Crucially, neuronal damage was also significantly reduced in rats treated with Indip 120 min after transient middle cerebral artery occlusion, which suggests that this agent has neuroprotective ...

The biological factors secreted by these cells have unique anti-inflammatory and neuroprotective effects. Presently, the company is looking for partners to drive clinical drug development of its ...

Huntington’s Disease (HD) is a fatally inherited neurodegenerative, orphan disorder affecting 1 in 10,000 individuals with a higher prevalence in Caucasian race. HD is caused by an expanded glutamine ...

Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, ...

The loss of retinal ganglion cells (RGCs) is a prevalent characteristic of glaucoma and often the reason behind disease progression. Now, a team of researchers has utilized AI to identify a RIPK3 ...